全体要約
外分泌膵不全は、外分泌膵酵素の不足を特徴とする医療状態です。2022年の世界の外分泌膵不全治療薬市場は、地域別および市場セクター別に分析され、2023年から2029年の予測が示されています。市場は、膵酵素補充療法や栄養療法などの製品タイプ、病院薬局や小売薬局などのアプリケーションに分かれています。
主要な企業には、AbbVie、Janssen Pharmaceuticals、Allergan、AzurRx、CHIESI Farmaceutici S.p.A.が含まれ、2022年には上位2社が市場の大部分を占めました。アメリカ、ヨーロッパ、中国などの地域での成長が見込まれ、各地域の市場規模や成長機会が詳細に分析されています。
関連する質問
AbbVie, Janssen Pharmaceuticals, Allergan, AzurRx, CHIESI Farmaceutici S.p.A.
製品セグメンテーションの重要なトレンド, 主要企業の戦略分析, 地域別市場の成長機会
概要
LPI (LP Information)の最新の調査報告書「外分泌膵機能不全治療業界の予測」では、過去の売上を調査し、2022年の世界の外分泌膵機能不全治療の総売上をレビューしています。また、2023年から2029年までの外分泌膵機能不全治療の売上予測について、地域別および市場セクター別に包括的な分析を提供。外分泌膵機能不全治療の売上が地域、市場セクター、サブセクター別に分かれているため、この報告書では、世界の外分泌膵機能不全治療業界の詳細な分析を数百万USドル単位で提供。
このインサイトレポートは、世界の外分泌膵不全治療の状況に関する包括的な分析を提供し、製品のセグメンテーション、企業の形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、このレポートは、外分泌膵不全治療ポートフォリオと能力、市場参入戦略、市場ポジション、地理的展開に焦点を当て、世界の外分泌膵不全治療市場の加速する中で、これらの企業のユニークなポジションをよりよく理解するために、主要なグローバル企業の戦略を分析しています。
このインサイトレポートは、外分泌膵不全治療に関するグローバルな見通しを形成する主要な市場動向、ドライバー、影響要因を評価し、タイプ、アプリケーション、地域、及び市場規模別に予測を分解して、新たな機会の発生ポケットを強調します。数百のボトムアップの質的および量的市場入力に基づく透明な方法論を用いたこの研究予測は、グローバルな外分泌膵不全治療の現在の状態と将来の軌道について非常に微細な見解を提供します。
世界の外分泌膵不全治療市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長することが予測されています。また、2023年から2029年にかけてXX%のCAGRで成長することが期待されています。
アメリカの外分泌膵機能不全治療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると予測されており、2023年から2029年までの年間平均成長率（CAGR）はXX%です。
中国の外分泌膵不全治療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加する見込みであり、2023年から2029年までの間にXX%のCAGRを記録する見込みです。
ヨーロッパの外分泌膵不全治療薬市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までのCAGRはXX%です。
グローバルな主要な外分泌膵不全治療のプレーヤーには、AbbVie、Janssen Pharmaceuticals、Allergan、AzurRx、CHIESI Farmaceutici S.p.A.などが含まれます。収益の面では、2022年において、世界の2大企業がほぼXX%のシェアを占めていました。
この報告書は、製品タイプ、アプリケーション、主要プレーヤー、および主要地域と国別の外分泌膵不全治療市場の包括的な概要、市場シェア、および成長機会を提示します。
市場セグメンテーション：
タイプ別セグメンテーション
膵臓酵素補充療法
栄養療法
アプリケーションによるセグメンテーション
病院薬局
小売薬局およびドラッグストア
その他
このレポートは地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下でプロファイルされた企業は、主要な専門家から収集した情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析して選定されました。
アッヴィ
ヤンセンファーマシューティカルト
アラガン
アズールRX
キエジファルマシューティチ S.p.A.
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの外分泌膵不全治療薬市場規模、（2018年～2029年）
2.1.2 外分泌膵不全治療薬市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 外分泌膵不全治療薬セグメント、タイプ別
2.2.1 膵酵素補充療法
2.2.2 栄養療法
2.3 外分泌膵不全治療薬市場規模：タイプ別
2.3.1 外分泌膵不全治療薬市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの外分泌膵不全治療薬市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 外分泌膵不全治療薬セグメント、用途別
2.4.1 病院内薬局
2.4.2 小売薬局・ドラッグストア
2.4.3 その他
2.5 外分泌膵不全治療薬市場規模：用途別
2.5.1 外分泌膵不全治療薬市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの外分泌膵不全治療薬市場規模、市場シェア（用途別）（2018年～2023年）
3 外分泌膵不全治療薬市場規模：プレイヤー別
3.1 外分泌膵不全治療薬市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける外分泌膵不全治療薬市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける外分泌膵不全治療薬市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの外分泌膵不全治療薬市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 外分泌膵不全治療薬、地域別
4.1 外分泌膵不全治療薬市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける外分泌膵不全治療薬市場規模成長（2018年〜2023年）
4.3 APACにおける外分泌膵不全治療薬市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける外分泌膵不全治療薬市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける外分泌膵不全治療薬市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける外分泌膵不全治療薬市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける外分泌膵不全治療薬市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける外分泌膵不全治療薬市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける外分泌膵不全治療薬市場規模、地域別（2018年〜2023年）
6.2 APACにおける外分泌膵不全治療薬市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける外分泌膵不全治療薬市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの外分泌膵不全治療薬 国別（2018年～2023年）
7.2 ヨーロッパにおける外分泌膵不全治療薬市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける外分泌膵不全治療薬市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの外分泌膵不全治療薬 地域別（2018年～2023年）
8.2 中東・アフリカにおける外分泌膵不全治療薬市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける外分泌膵不全治療薬市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの外分泌膵不全治療薬市場、市場予測
10.1 グローバルの外分泌膵不全治療薬、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの外分泌膵不全治療薬、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの外分泌膵不全治療薬、市場予測
10.1.3 APACの外分泌膵不全治療薬、市場予測
10.1.4 ヨーロッパの外分泌膵不全治療薬、市場予測
10.1.5 中東・アフリカの外分泌膵不全治療薬、市場予測
10.2 アメリカズの外分泌膵不全治療薬、市場予測（国別）（2024年～2029年）
10.3 APACの外分泌膵不全治療薬、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの外分泌膵不全治療薬、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの外分泌膵不全治療薬、市場予測（地域別）（2024年～2029年）
10.6 グローバルの外分泌膵不全治療薬、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの外分泌膵不全治療薬、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 AbbVie
11.1.1 AbbVie：企業情報
11.1.2 AbbVie：外分泌膵不全治療薬分野の提供製品
11.1.3 AbbVie：外分泌膵不全治療薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 AbbVie：主要事業概要
11.1.5 AbbVie：直近の展開
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals：企業情報
11.2.2 Janssen Pharmaceuticals：外分泌膵不全治療薬分野の提供製品
11.2.3 Janssen Pharmaceuticals：外分泌膵不全治療薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Janssen Pharmaceuticals：主要事業概要
11.2.5 Janssen Pharmaceuticals：直近の展開
11.3 Allergan
11.3.1 Allergan：企業情報
11.3.2 Allergan：外分泌膵不全治療薬分野の提供製品
11.3.3 Allergan：外分泌膵不全治療薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Allergan：主要事業概要
11.3.5 Allergan：直近の展開
11.4 AzurRx
11.4.1 AzurRx：企業情報
11.4.2 AzurRx：外分泌膵不全治療薬分野の提供製品
11.4.3 AzurRx：外分泌膵不全治療薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 AzurRx：主要事業概要
11.4.5 AzurRx：直近の展開
11.5 CHIESI Farmaceutici S\.p\.A
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Exocrine Pancreatic Insufficiency Therapeutic Industry Forecast” looks at past sales and reviews total world Exocrine Pancreatic Insufficiency Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Exocrine Pancreatic Insufficiency Therapeutic sales for 2023 through 2029. With Exocrine Pancreatic Insufficiency Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exocrine Pancreatic Insufficiency Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Exocrine Pancreatic Insufficiency Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Exocrine Pancreatic Insufficiency Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exocrine Pancreatic Insufficiency Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exocrine Pancreatic Insufficiency Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exocrine Pancreatic Insufficiency Therapeutic.
The global Exocrine Pancreatic Insufficiency Therapeutic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Exocrine Pancreatic Insufficiency Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Exocrine Pancreatic Insufficiency Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Exocrine Pancreatic Insufficiency Therapeutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Exocrine Pancreatic Insufficiency Therapeutic players cover AbbVie, Janssen Pharmaceuticals, Allergan, AzurRx and CHIESI Farmaceutici S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Exocrine Pancreatic Insufficiency Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pancreatic Enzyme Replacement Therapy
Nutritional Therapy
Segmentation by application
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Janssen Pharmaceuticals
Allergan
AzurRx
CHIESI Farmaceutici S.p.A.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size 2018-2029
2.1.2 Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Exocrine Pancreatic Insufficiency Therapeutic Segment by Type
2.2.1 Pancreatic Enzyme Replacement Therapy
2.2.2 Nutritional Therapy
2.3 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
2.3.1 Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Exocrine Pancreatic Insufficiency Therapeutic Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies & Drug Stores
2.4.3 Others
2.5 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
2.5.1 Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023)
3 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Player
3.1 Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Players
3.1.1 Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Exocrine Pancreatic Insufficiency Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exocrine Pancreatic Insufficiency Therapeutic by Regions
4.1 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth (2018-2023)
4.3 APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth (2018-2023)
4.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth (2018-2023)
5 Americas
5.1 Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2018-2023)
5.2 Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023)
5.3 Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2018-2023)
6.2 APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023)
6.3 APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exocrine Pancreatic Insufficiency Therapeutic by Country (2018-2023)
7.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023)
7.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.1 Global Exocrine Pancreatic Insufficiency Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Exocrine Pancreatic Insufficiency Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Exocrine Pancreatic Insufficiency Therapeutic Forecast
10.1.3 APAC Exocrine Pancreatic Insufficiency Therapeutic Forecast
10.1.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Forecast
10.1.5 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Forecast
10.2 Americas Exocrine Pancreatic Insufficiency Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.2.2 Canada Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.2.3 Mexico Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.2.4 Brazil Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3 APAC Exocrine Pancreatic Insufficiency Therapeutic Forecast by Region (2024-2029)
10.3.1 China Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3.2 Japan Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3.3 Korea Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3.4 Southeast Asia Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3.5 India Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.3.6 Australia Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.4.2 France Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.4.3 UK Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.4.4 Italy Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.4.5 Russia Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.5 Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.5.2 South Africa Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.5.3 Israel Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.5.4 Turkey Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.5.5 GCC Countries Exocrine Pancreatic Insufficiency Therapeutic Market Forecast
10.6 Global Exocrine Pancreatic Insufficiency Therapeutic Forecast by Type (2024-2029)
10.7 Global Exocrine Pancreatic Insufficiency Therapeutic Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Exocrine Pancreatic Insufficiency Therapeutic Product Offered
11.1.3 AbbVie Exocrine Pancreatic Insufficiency Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Information
11.2.2 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Product Offered
11.2.3 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Janssen Pharmaceuticals Main Business Overview
11.2.5 Janssen Pharmaceuticals Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Exocrine Pancreatic Insufficiency Therapeutic Product Offered
11.3.3 Allergan Exocrine Pancreatic Insufficiency Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 AzurRx
11.4.1 AzurRx Company Information
11.4.2 AzurRx Exocrine Pancreatic Insufficiency Therapeutic Product Offered
11.4.3 AzurRx Exocrine Pancreatic Insufficiency Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AzurRx Main Business Overview
11.4.5 AzurRx Latest Developments
11.5 CHIESI Farmaceutici S.p.A.
11.5.1 CHIESI Farmaceutici S.p.A. Company Information
11.5.2 CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Product Offered
11.5.3 CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 CHIESI Farmaceutici S.p.A. Main Business Overview
11.5.5 CHIESI Farmaceutici S.p.A. Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Pancreatic Enzyme Replacement Therapy Table 3. Major Players of Nutritional Therapy Table 4. Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Table 7. Exocrine Pancreatic Insufficiency Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Table 10. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Player (2018-2023) Table 12. Exocrine Pancreatic Insufficiency Therapeutic Key Players Head office and Products Offered Table 13. Exocrine Pancreatic Insufficiency Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Regions (2018-2023) Table 18. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Country (2018-2023) Table 22. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Table 24. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Table 26. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Region (2018-2023) Table 28. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Table 30. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Table 32. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Country (2018-2023) Table 34. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Table 36. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Exocrine Pancreatic Insufficiency Therapeutic Table 45. Key Market Challenges & Risks of Exocrine Pancreatic Insufficiency Therapeutic Table 46. Key Industry Trends of Exocrine Pancreatic Insufficiency Therapeutic Table 47. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. AbbVie Details, Company Type, Exocrine Pancreatic Insufficiency Therapeutic Area Served and Its Competitors Table 52. AbbVie Exocrine Pancreatic Insufficiency Therapeutic Product Offered Table 53. AbbVie Exocrine Pancreatic Insufficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. AbbVie Main Business Table 55. AbbVie Latest Developments Table 56. Janssen Pharmaceuticals Details, Company Type, Exocrine Pancreatic Insufficiency Therapeutic Area Served and Its Competitors Table 57. Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Product Offered Table 58. Janssen Pharmaceuticals Main Business Table 59. Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Janssen Pharmaceuticals Latest Developments Table 61. Allergan Details, Company Type, Exocrine Pancreatic Insufficiency Therapeutic Area Served and Its Competitors Table 62. Allergan Exocrine Pancreatic Insufficiency Therapeutic Product Offered Table 63. Allergan Main Business Table 64. Allergan Exocrine Pancreatic Insufficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Allergan Latest Developments Table 66. AzurRx Details, Company Type, Exocrine Pancreatic Insufficiency Therapeutic Area Served and Its Competitors Table 67. AzurRx Exocrine Pancreatic Insufficiency Therapeutic Product Offered Table 68. AzurRx Main Business Table 69. AzurRx Exocrine Pancreatic Insufficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. AzurRx Latest Developments Table 71. CHIESI Farmaceutici S.p.A. Details, Company Type, Exocrine Pancreatic Insufficiency Therapeutic Area Served and Its Competitors Table 72. CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Product Offered Table 73. CHIESI Farmaceutici S.p.A. Main Business Table 74. CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. CHIESI Farmaceutici S.p.A. Latest Developments List of Figures Figure 1. Exocrine Pancreatic Insufficiency Therapeutic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Exocrine Pancreatic Insufficiency Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Exocrine Pancreatic Insufficiency Therapeutic Sales Market Share by Country/Region (2022) Figure 8. Exocrine Pancreatic Insufficiency Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type in 2022 Figure 10. Exocrine Pancreatic Insufficiency Therapeutic in Hospital Pharmacies Figure 11. Global Exocrine Pancreatic Insufficiency Therapeutic Market: Hospital Pharmacies (2018-2023) & ($ Millions) Figure 12. Exocrine Pancreatic Insufficiency Therapeutic in Retail Pharmacies & Drug Stores Figure 13. Global Exocrine Pancreatic Insufficiency Therapeutic Market: Retail Pharmacies & Drug Stores (2018-2023) & ($ Millions) Figure 14. Exocrine Pancreatic Insufficiency Therapeutic in Others Figure 15. Global Exocrine Pancreatic Insufficiency Therapeutic Market: Others (2018-2023) & ($ Millions) Figure 16. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application in 2022 Figure 17. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Player in 2022 Figure 18. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Regions (2018-2023) Figure 19. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size 2018-2023 ($ Millions) Figure 20. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size 2018-2023 ($ Millions) Figure 21. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size 2018-2023 ($ Millions) Figure 23. Americas Exocrine Pancreatic Insufficiency Therapeutic Value Market Share by Country in 2022 Figure 24. United States Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Region in 2022 Figure 29. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type in 2022 Figure 30. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application in 2022 Figure 31. China Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 35. India Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Country in 2022 Figure 38. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Figure 39. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Figure 40. Germany Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 41. France Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share by Application (2018-2023) Figure 48. Egypt Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 54. APAC Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 55. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 57. United States Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 58. Canada Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 59. Mexico Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 60. Brazil Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 61. China Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 62. Japan Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 63. Korea Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 65. India Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 66. Australia Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 67. Germany Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 68. France Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 69. UK Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 70. Italy Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 71. Russia Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 72. Spain Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 73. Egypt Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 74. South Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 75. Israel Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 76. Turkey Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Exocrine Pancreatic Insufficiency Therapeutic Market Size 2024-2029 ($ Millions) Figure 78. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Market Share Forecast by Application (2024-2029)
